Sec31A Antibody [J15M23]

Catalog No.: F8573

    Application: Reactivity:
    • Lane 1: MCF7, Lane 2: SKOV-3, Lane 3: K562
    1/

    当該製品は品切れ状态で、ごメールアドレスを教えていただければ、在庫があると、メールで顧客様に伝えます。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    1:400
    Application
    WB, IF
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human, Mouse, Rat, Monkey
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    95-140 kDa

    Datasheet & SDS

    生物学的記述

    Specificity
    Sec31A Antibody [J15M23] detects endogenous levels of total Sec31A protein.
    Clone
    J15M23
    Synonym(s)
    Protein transport protein Sec31A; SEC31A
    Background
    Sec31A is a core subunit of the coat protein complex II (COPII), a multimeric coat that mediates the formation of transport vesicles at the interface between the endoplasmic reticulum and the Golgi apparatus. Sec31A forms a β‑propeller WD‑repeat domain that interacts with Sec13 and self‑assembles into flexible, cage‑like scaffolds that physically shape budding COPII vesicles and simultaneously stimulate the GTPase activity of the Sar1–Sec23/24 inner coat complex, thereby coordinating the recruitment, deformation, and fission of ER‑derived carriers. Sec31A also contains a proline‑rich C‑terminal region that binds regulatory proteins and calcium‑sensing factors such as ALG‑2 and annexin‑A11, enabling luminal–cytosolic crosstalk and Ca²⁺‑dependent modulation of coat stability and vesicle‑budding kinetics, and its ubiquitously expressed isoform contrasts with the more restricted Sec31B paralog, whose expression peaks in brain and testis. Sec31A helps couple COPII assembly to ER‑export signals, ensuring that nascent secretory and membrane proteins are packaged into ER‑to‑Golgi carriers, and disruption of Sec31A function delays cargo exit, perturbs ER‑Golgi trafficking, and impairs secretion and cell‑surface delivery. Chromosomal rearrangements generate an SEC31A–JAK2 fusion that drives constitutive JAK2 kinase activity and downstream STAT‑dependent signaling, rendering cells sensitive to JAK inhibitors.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください